Colgate-Palmolive Co (CL)

CL (NYSE:Consumer Non-Durables) EQUITY
$71.16
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | CL Avg Daily Volume: 3,299,400
Last Update: 04/28/16 - 4:01 PM EDT
Volume: 0
YTD Performance: 6.81%
Open: $0.00
Previous Close: $71.16
52 Week Range: $50.84 - $71.79
Oustanding Shares: 892,738,516
Market Cap: 61,875,706,544
6-Month Chart
TheStreet Ratings Grade for CL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 0 0 1
Moderate Buy 1 1 1 1
Hold 15 15 15 15
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.94 2.94 2.94 2.82
Latest Dividend: 0.39
Latest Dividend Yield: 2.25%
Dividend Ex-Date: 04/20/16
Price Earnings Ratio: 45.60
Price Earnings Comparisons:
CL Sector Avg. S&P 500
45.60 45.60 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.44% 3.48% 19.61%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.20 -0.10 -0.02
Net Income -33.80 -0.40 -0.16
EPS -35.50 -0.40 -0.16
Earnings for CL:
EBITDA 4.38B
Revenue 16.03B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.67 $0.71 $2.77 $3.00
Number of Analysts 8 8 12 11
High Estimate $0.70 $0.74 $2.85 $3.08
Low Estimate $0.66 $0.70 $2.70 $2.90
Prior Year $0.70 $0.72 $2.81 $2.77
Growth Rate (Year over Year) -3.57% -0.87% -1.60% 8.56%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Carley Garner

 | Apr 11, 2016 | 6:00 AM EDT

But the technical picture is bullish in the short term.

By

Carley Garner

 | Apr 8, 2016 | 12:00 PM EDT

But the technical picture is bullish in the short-term. 

By

Doug Kass

 | Mar 15, 2016 | 4:02 PM EDT
Inside day for the markets today. Ns over Ss and Rs (Russell was quite weak, down $1.54, probably related to biotech/health care. Note: iShares Russell 2000 (IWM) short is a recent Best Ideas List inclusion as a short.  The U.S. dollar weakened, though multinationals/staples -- including Procter & Gamble (PG), Colgate-Palmolive (CL) and Kimberly-Clark (KMB) -- were mixed.  Crude oil dropped 71 cents to $36.44. Natural gas rose by three cents. Gold fell by $14.70, continuing its recent correction. Silver was down an outsized 25 cents. (Boca Biff called, and he is squirming now. Stay tuned). Agricultural commodities:  wheat, corn and oats down small. Bonds were essentially unchanged, with  yields up a basis point. Municipals were also flattish and closed-end municipal funds sold off. High yield was lower. However, Blackstone/GSO Strategic Credit Fund (BGB) forged ahead by six cents and now stands up about 10% from January lows. I continue to buy. Credit is underpriced. If it isn't, stocks are materially overpriced!  Banks continued an orderly drop, but comparatively small. I would love to see a more meaningful decline because I want to re-up my financial holdings, with an intermediate-term view. Hit me with your best shot!  Life insurance starting to roll over? I am long Hartford Financial Services Group (HIG) and short Lincoln National (LNC) and MetLife (MET). Brokerages, recently sold and taken off the Best Ideas List, appear to be rolling over for another loss. Morgan Stanley (MS) was down 50 cents and Goldman Sachs (GS) down $1.35. Private equity is rolling over, too. Blackstone Group (BX) was down 40 cents. Old tech was unchanged. Media weakness; my shorts Comcast (CMCSA) and Disney (DIS) were lower. Biowreck -- down nearly 4%.  Retail was mixed, with remodeling in the form of Home Depot (HD) and Lowe's (LOW) was a highlight. I am market-neutral in the space. (T)FANG continues to exert some leadership. Tesla (TSLA) and Amazon (AMZN) were strong components. NOSH was tasty, as all four components were better. CRABBY flatlined. Recent sales of Potash (POT), Twitter (TWTR) and Radian Group (RDN) are looking OK for now. I like the short set-up now; a tepid rally from the lows. SPDR S&P 500 ETF (SPY) was down $1.30 at the worst, rallied to be only down 40 cents and was off 60 cents near the close. I added to ProShares UltraShort S&P 500 ETF (SDS) small. A trade, not a long-term lease!  I sold Best Idea long Best Buy (BBY). Yesterday's Trades of the Week -- inverse Nasdaq ETFs ProShares Short QQQ (PSQ), ProShares UltraShort QQQ (QID) and ProShares UltraPro Short QQQ (SQQQ) -- were up marginally. Some good stuff on RealMoneyPro today: 1. Mo' Cross on gold. But Skip Raschke prefers platinum over gold. (It's a no-brainer? Uh ho! I hate that term, as respectfully nothing is a no-brainer, Carl Icahn!)  2. Tim "Not Phil or Judy" Collins sees yellow flags.  3. James Passeri on
By

Tony Owusu

 | Mar 11, 2016 | 8:35 AM EST

U.S. indices could see gains today if oil continues to cooperate with the rally. 

By

Timothy Collins

 | Mar 9, 2016 | 11:50 AM EST

XLP is full of what's good for your portfolio.

By

Doug Kass

 | Mar 1, 2016 | 4:05 PM EST
The U.S. dollar strengthened modestly. Crude oil increased by 66 cents to $34.41. Gold was flat. Agricultural commodities saw wheat, soybean and corn trade up. Bonds got blasted, with the iShares 20+ Year Treasury Bond ETF (TLT) down $2.50) -- an important feature of the day. Longer-dated yield increased by about eight basis points and the yield curve, as an aid to bank stocks, steepened. Municipals got hit. High yield continued to rally after starting the day lower. Blackstone/GSO Strategic Credit Fund (BGB), the object of my affection yesterday (I noted last week's junk bond inflows) and almost every day, rose 31 cents to $12.73. I highlighted BGB yesterday as a favored idea.   Banks were the world's fair after several days of underperformance. The sector recorded a 4% to 5% gain, highlighted by the three money center banks, Citigroup (C), Bank of America (BAC) and JPMorgan Chase (JPM). I have seven banks stocks on my Best Ideas List.  Brokerages and private equity were also strong, with Goldman Sachs (GS) up $4.50, Morgan Stanley (MS) up $1.25 and Blackstone Group (BX) up $1.25. All three are on my Best Ideas List.  Insurance stocks ripped higher. I am offering Lincoln National (LNC) and MetLife (MET) to re-establish my shorts. Berkshire Hathaway (BRK.B) was up in my face but Hartford Financial Services Group (HIG) and Allstate (ALL) are trading well. Retail was strong, led by Bed, Bath & Beyond (BBBY) up $1.40 and Macy's (M) making a new recent high near $44 a share. Consumer staples were led by Procter & Gamble (PG), up $1, Colgate-Palmolive (CL), up $1.65, and Kimberly-Clark (KMB) +$1.35. Old tech prospered, with IBM (IBM) up $3.40; Intel (INTC), Cisco (CSCO) and Microsoft (MSFT) were up nearly 3% each. Autos were strong, but no better than the opening. I shorted General Motors (GM) and Ford (F). Here is my rationale for "Peak Autos." From Peter Boockvar: According to Ward's Automotive, February vehicle sales totaled 17.43mm SAAR vs 17.46mm in January and below the estimate of a lift to 17.70mm. After 3 straight months of 18mm+ in September thru November, the last 3 months have been in the 17mm range. The question of peak auto sales is becoming more front and center as via easy access to credit we've pulled forward a lot of potential future sales. Over the weekend the WSJ reported that in Q4, "auto loans that are 30-89 days overdue rose to 1.82% of total auto loans...the highest level since 2011." The article stressed that this ratio reflected auto loans kept on bank balance sheets which are typically the better credits as opposed to those off loaded into an ABS. For ABS, Fitch last week said that "delinquencies of over 60 days on securities backed by subprime auto loans hit almost 5% in January. That is the highest since September 2009 and close to the record peak hit that same year." Biotech even rallied after conspicuous recent underperformance, up 4% with Allergan (AGN) and AbbVie (ABBV) leading. Valeant Pharmaceuticals (VRX) even reversed but still was in the red. My Biotech Basket was broadly higher, led by Acadia Pharmaceuticals (ACAD), Celgene (CELG), Gilead Sciences (GILD), Portola Pharmaceuticals (PTLA), Otonomy (OTIC) up 8% and Interxon (XON) up $2.50. (T)FANG, ex Tesla (TSLA) -- Citron report hurt -- was broadly higher.   NOSH's four components drove higher, too. CRABBY broadly up, with C and BGB leading. Serial portfolio laggards are beginning to catch up -- Radian Group (RDN) up 5% and Potash (POT) up 50 cents. Apple (AAPL), a short, caught up and is trading close to par, even though Cleveland Research has cautious comments. I identified DuPont (DD) as one of my favorite stocks of the year, and it rose by $2 today, to a new recent high. Net net, I added small to my net short exposure, but I added to longs and to shorts at the same time. I did average in further (on a scale -- cost under $21) on ProShares UltraShort S&P 500 (SDS). Here is some good stuff on RealMoneyPro today: Jim "El Capitan" Cramer's market map.  Sham Gad on value investing.  RevShark on a

bearishColgate downgraded at Sterne Agee

Feb 26, 2016 | 7:55 AM EST

CL was downgraded from Buy to Neutral, Sterne Agee CRT said. Valuation call. 

By

Doug Kass

 | Feb 17, 2016 | 3:26 PM EST
"Who's on First?"  -- damned if I know! The market trended higher from the get go. Machines and algos in full gear. At 230 p.m. ET the S&P was at its high, with a gain of  nearly 35 handles on little news. My guess, with SPDR S&P 500 ETF (SPY) at $193.20, is that we are at the high for the day. I continue to scale into SPY short. The first back-to-back-to-back 1% gains for the S&P since October 2011. Lesson learned (again!)  Avoid the self-confident in view. So many were confidently bearish last week. Today, they forgot or swept their views under the rug. This condition has no value to us, and increasingly talking heads should be ignored.  The U.S. dollar strengthened. Consumer nondurables were strong nonetheless, with broad gains in Kimberly-Clark (KMB), Colgate-Palmolive (CL) and Procter & Gamble (PG). Bonds fell again in price. iShares 20+ Year Treasury Bond (TLT) is down to around $129; it was $136 a few days ago. The yield on the 10-year U.S. note rose by seven basis points, and so did the 30-year bond. Municipals were also hit, as were closed-end municipal bond funds. The junk market served up a good course -- iShares iBoxx $ High Yield Corporate Bond ETF (HYG) was up 76 cents and SPDR Barclays High Yield Bond ETF (JNK) was up 32 cents. But, another modest rally for Blackstone/GSO Strategic Credit Fund (BGB), which just regained what it lost yesterday. Crude oil spurted by $1.72 to $30.76. Natural gas rose by four cents. Energy stocks gushed, with Schlumberger (SLB) up $1.30) Gold was up $1. Banks continued their winning streak. Speculative buy Deutsche Bank (DB) was a standout, up 4%. However, there was some weakness -- Wells Fargo (WFC), Comerica (CMA), Southern National Bancorp of Virginia (SONA) and Fifth Third Bancorp (FITB) were lower. JPMorgan Chase (JPM) was teetering after its big run, up only about a quarter. Retail still is strong, with broad-based gains in Home Depot (HD), Macy's (M), Best Buy (BBY) and Bed, Bath and Beyond (BBBY) -- again! Biotech broke out and is the world's fair. Our speculative stocks in the basket spurted higher. However, Gilead Sciences (GILD) was lower on the day. Old tech thrived, with IBM (IBM) up $4, Intel (INTC) up 3%, Cisco (CSCO) up 2% and Microsoft  (MSFT) up 3%. TFANG was broadly higher, led by Telsa (TSLA) and Facebook (FB). NOSH was tasty, too, but not as much as its high octane brethren, with modest gains in Starbucks (SBUX) and HD. CRABBY was six for six higher, led by Citigroup (C). Twitter (TWTR) got jiggy, up $1.14, but I have been disappointed before in this name. DuPont (DD) was strong, and I pared back. PG was up $1.15 (a favorite). Potash (POT) benefited from the rotation back into cyclicals. iShares China Large-Cap ETF (FXI) rallied for a second day in a row; I remain short and would add up to another 3% to 4% to my short.  My
By

Christopher Versace

 | Feb 5, 2016 | 9:02 AM EST

The jobs miss means investors will once again be scrubbing their growth expectations.

By

Jim Cramer

 | Jan 18, 2016 | 10:53 AM EST

At this moment we should be embracing European equities.

1. Unmasking Zero Hedge 2. Tech as In Wreck (I really think this is a good column , at lea...

Took a small loss. But sized properly given my risk profile.

Markets turn down in second half of day. As I stated in my column today, lots of high pro...
In today's BOJ Meeting, Kuroda & Co., decided to forgo any additional stimulus measure...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.